Isaacs A J, Britton A R, McPherson K
Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, England.
BMJ. 1995 Nov 25;311(7017):1399-401. doi: 10.1136/bmj.311.7017.1399.
To ascertain the prevalence and duration of use of hormone replacement therapy by menopausal women doctors.
Postal questionnaire.
General practices in the United Kingdom.
Randomised stratified sample of women doctors who obtained full registration between 1952 and 1976, taken from the current principal list of the Medical Register.
Prevalence and duration of use of hormone replacement therapy; menopausal status.
Overall, 45.7% (436/954) of women doctors aged between 45 and 65 years had ever used hormone replacement therapy. When the results from women still menstruating regularly were excluded, 55.2% (428) were ever users and 41.2% (319) current users. The cumulative probability of remaining on hormone replacement therapy was 0.707 at five years and 0.576 at 10 years.
Women doctors have a higher prevalence of use of hormone replacement therapy than has been reported for other women in the United Kingdom, and most users seem to be taking hormone replacement therapy for more than five years. The results may become generalisable to the wider population as information on the potential benefits of hormone replacement therapy is disseminated.
确定绝经女性医生使用激素替代疗法的患病率及使用时长。
邮寄问卷调查。
英国的全科医疗诊所。
从《医学注册名录》当前主要名单中随机分层抽取的1952年至1976年间获得完全注册的女性医生样本。
激素替代疗法的使用患病率及使用时长;绝经状态。
总体而言,年龄在45至65岁之间的女性医生中,45.7%(436/954)曾使用过激素替代疗法。排除仍有规律月经的女性的结果后,55.2%(428人)曾使用过,41.2%(319人)为当前使用者。持续使用激素替代疗法5年时的累积概率为0.707,10年时为0.576。
与英国其他女性相比,女性医生使用激素替代疗法的患病率更高,且大多数使用者使用激素替代疗法的时间超过5年。随着激素替代疗法潜在益处信息的传播,这些结果可能适用于更广泛的人群。